Oct 28, 2022 03:34PM
Oct 28, 2022 03:33PM
Oct 3, 2022 09:00AM
Sep 1, 2022 04:08PM
Sep 1, 2022 04:05PM
Aug 8, 2022 04:05PM
May 31, 2022 09:03AM Y-mAbs Therapeutics (YMAB) Announces FDA Acceptance of Biologics License Application for OMBLASTYS for the Treatment of Neuroblastoma for Priority Review
May 31, 2022 09:00AM
Nov 5, 2020 04:01PM
Oct 16, 2020 09:00AM
Oct 16, 2020 09:00AM
Jul 27, 2020 04:01PM
Jun 2, 2020 09:02AM
Jun 2, 2020 09:00AM Y-mAbs Announces U.S. FDA Acceptance of Biologics License Application for Danyelza™ (naxitamab) for the Treatment of Neuroblastoma for Priority Review

14,982 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All